In this Section |
224516 Improving treatment adherence of breast cancer multimodal patients through patient navigationMonday, November 8, 2010
Introduction: African American compared to white women in the U.S. are diagnosed with later stage breast cancer (BC), experience longer treatment delays, are less likely to receive/complete treatment according to recommended guidelines and have a 36% higher mortality rate. A Patient Navigation (PN) program can help patients overcome barriers to treatment adherence. As a Continuous Quality Improvement study at a large inner city cancer center hospital, this study documents the PN program's influence on compliance with two National Quality Forum (NQF) breast indicators: 1) chemotherapy discussed/administered for patients <70 years old (yo) with >1cm triple negative BC and 2) radiation therapy for patients <70 yo with Stage I-III BC treated with lumpectomy. Method: This cohort study consisted of 34 multimodal BC patients who were predominately low-income, African American, and referred to the PN program. PN services included phone support, home visits, appointment attendance, support groups and incentives. Data collection included demographics, preexisting health conditions, health risk behaviors, barriers to care and treatment recommendations. Patients were followed until treatment completion or failed compliance. Results: The standard of treatment (radiation and chemotherapy) compliance in 2006 was 74.4%, 75% respectively and the 2008 multimodal patients were 100%, 93% compliant, which was also higher than the 2008 overall BC patient adherence 95.8%, 93.7%. Conclusions: Higher rates of treatment adherence were obtained with the assistance of a PN program in at-risk, multimodal patients. These findings demonstrate the importance of PN program in eliminating barriers and disparities in the treatment of African American, multimodal BC patients.
Learning Areas:
Administer health education strategies, interventions and programsLearning Objectives: Keywords: Breast Cancer Programs, African American
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am qualified to present because I was the Principal Investigator on the Multimodal breast cancer patient treatment adherence project. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3081.2: Public Health Perspectives on Cancer Treatment and Survivorship
|